Details Basic Details Date Friday, August 25, 2017 Type Presentation Medical Product rivaroxaban Health Outcome(s) gastrointestinal (GI) bleed, intracranial hemorrhage, ischemic stroke Materials Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System Additional Information Information Host 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) PROMPT: Rivaroxaban Surveillance Publication: Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System Sentinel Drug Study: Xarelto (Rivaroxaban) & Gastrointestinal (GI) Bleed, Intracranial Hemorrhage, and Ischemic Stroke Contributors Presenter(s) Elizabeth Chrischilles